Pharma/Biotech Industries to modulate their operations to suit the massive pharmacovigilance headway
Product safety has geared up to what we call ‘optimal’
Product safety has geared up to what we call ‘optimal’
These are few of the questions raised by Webinar audience
Regulatory deviations that need major corrective actions require huge investment